Early Use of Sotrovimab in Children
A Case Report of an 11-Year-Old Kidney Transplant Recipient Infected with Sars-CoV-2
Bibliographic Data
| ID | 15719151 |
|---|---|
| Authors | Costanza Di Chiara (0000-0002-3586-0612, University of Padua, corresponding author), Daniele Mengato (0000-0003-1374-1505, University of Padua), Marica De Pieri (University of Padua), Germana Longo (University of Padua), Elisa Benetti (0000-0002-0819-604X, University of Padua), Francesca Venturini (0000-0003-2562-9932, University of Padua), Carlo Giaquinto (0000-0001-9365-0413, University of Padua), Daniele Donà (0000-0001-7105-2105, University of Padua) |
| Year | 2022 |
| Volume | 9 |
| Issue | 4 |
| Pages | 451-451 |
| Publication date | 2022-03-23 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Children (JOURNAL) |
| Journal identifiers | ISSN: 2227-9067 • E-ISSN: 2227-9067 |
| Publisher | Multidisciplinary Digital Publishing Institute (PUBLISHER • CH) |
| DOI | 10.3390/children9040451 |
| PMID | 35455495 |
| OpenAlex | W4224307916 |
| Language | EN |
| References cited | 24 |
For the first time, we report the well-tolerated use of sotrovimab in children under 12 years old. As the pandemic affects children across the globe, urgent data on sotrovimab dosing in children with a higher risk of developing severe COVID-19 are needed
2019-20 coronavirus outbreak · Coronavirus disease 2019 (COVID-19 · Infectious disease (medical specialty · Kidney · Kidney transplant · Kidney transplantation · Outbreak · Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 · Antibiotics Pharmacokinetics and Efficacy · COVID-19 Clinical Research Studies · Medicine · Renal Transplantation Outcomes and Treatments · Internal Medicine · Pediatrics · Virology
| Highly cited | No |
|---|